• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Oseltamivir inhibits both viral entry and release but enhances apoptosis of cells infected with influenza A H1N1

tetano

Editor, Senior Moderator
Biochem Biophys Res Commun. 2013 Jan 17. pii: S0006-291X(13)00055-7. doi: 10.1016/j.bbrc.2013.01.019. [Epub ahead of print]
Oseltamivir inhibits both viral entry and release but enhances apoptosis of cells infected with influenza A H1N1.
Gao R, Du N, Liu D, Zhou J, Li Z, Zhu Y, Shu Y.
Source

Dept. of Influenza, Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention (China CDC), Beijing China 100226.
Abstract

Oseltamivir (Tamiflu) has been shown to be effective as a treatment and chemoprophylaxis for influenza virus infections. However, the safety consideration of oseltamivir should not be overlooked because adverse events associated with the drug have frequently been reported after the use of Tamiflu for the treatment of influenza patients. Here, we investigated oseltamivir's influence on viral load, apoptosis, and cytokine response of influenza A H1N1-infected A549 or THP-1 cells. In addition, we analyzed the effect of the drug on the function of influenza-infected NK cells after oseltamivir treatment. The results of our study suggest that oseltamivir may inhibit both viral entry and release but may also enhance apoptosis of infected cells and interfere with NK cell function during influenza infection.

Copyright ? 2013. Published by Elsevier Inc.

PMID:
23333739
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23333739
 
Back
Top Bottom